EFV
Eva Fortea Verdejo Wells Fargo Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
24
Avg Return
Past Year
Past Year
29%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
75%
Neutral
25%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Initiated
| $40 |
42%
upside
| 1 | -4.3% |
0
%
| 2 Mar ‘26 2 days ago |
|
|
|
Overweight
Maintained
| $15 |
47%
upside
| 2 | +14% |
0
%
| 27 Feb ‘26 5 days ago |
|
|
|
Overweight
Maintained
| $144 |
42%
upside
| 1 | +77% |
0
%
| 26 Feb ‘26 6 days ago |
|
|
|
Overweight
Maintained
| $53 |
13%
upside
| 1 | +20% |
0
%
| 25 Feb ‘26 7 days ago |
|
|
|
Equal-Weight
Downgraded
| $23 |
2%
upside
| 1 | +40% |
0
%
| 12 Feb ‘26 20 days ago |
|
|
|
Equal-Weight
Maintained
| $35 |
16%
downside
| 1 | – |
–
| 11 Feb ‘26 21 days ago |
|
|
|
Overweight
Upgraded
| $33 |
31%
upside
| 1 | +2.1% |
0
%
| 12 Dec ‘25 2 months ago |
|